Study population
| Variable | Ntotal | Statistic* |
|---|---|---|
| Age (years) | 997 | 65 (12–94) |
| Gender | ||
| Female | 446 | 45% |
| Male | 553 | 55% |
| Race | ||
| Caucasian | 803 | 82.4 |
| African-American | 167 | 17.1 |
| Other | 4 | 0.5 |
| ECOG PS | ||
| 0 | 34 | 3% |
| 1 | 150 | 16% |
| 2 | 252 | 26% |
| 3 | 403 | 42% |
| 4 | 120 | 12% |
| Primary cancer site | ||
| Lung | 239 | 24% |
| Breast | 87 | 9% |
| Colorectal | 79 | 8% |
| Prostate | 70 | 7% |
| Unknown primary | 62 | 6% |
| Pancreas | 57 | 6% |
| Head and neck | 46 | 5% |
| Kidney | 44 | 4% |
| Lymphoma | 32 | 3% |
| Oesophagus | 31 | 3% |
| Bladder | 26 | 3% |
| Myeloma | 19 | 2% |
| Melanoma | 17 | 2% |
| Cervix | 16 | 2% |
| Ovary | 14 | 1% |
| Uterus | 10 | 1% |
| Leukaemia | 9 | 1% |
| Other | 142 | 14% |
| Survival from diagnosis (months) | 838 | 14 (0–547) |
| Survival after referral (months) | 598 | 2 (0.5–33) |
*N (%) for categorical variables; median (range) for continuous variables.
ECOG, Eastern Cooperative Oncology Group; PS, performance score.